Dr Lal Pathlabs informs about schedule of analyst meet

04 Sep 2019 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting. 

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

2186.05 24.10 (1.11%)
Jul 01, 10:45 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 3640.00
Aster DM Healthcare 175.65
Narayana Hrudayalay 634.45
Dr. Lal Pathlabs 2186.05
Metropolis Health. 1406.20
View more..